1. Home
  2. IPWR vs PRLD Comparison

IPWR vs PRLD Comparison

Compare IPWR & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPWR
  • PRLD
  • Stock Information
  • Founded
  • IPWR 2007
  • PRLD 2016
  • Country
  • IPWR United States
  • PRLD United States
  • Employees
  • IPWR N/A
  • PRLD N/A
  • Industry
  • IPWR Industrial Machinery/Components
  • PRLD Medicinal Chemicals and Botanical Products
  • Sector
  • IPWR Industrials
  • PRLD Health Care
  • Exchange
  • IPWR Nasdaq
  • PRLD Nasdaq
  • Market Cap
  • IPWR 42.1M
  • PRLD 48.6M
  • IPO Year
  • IPWR 2013
  • PRLD 2020
  • Fundamental
  • Price
  • IPWR $4.70
  • PRLD $0.78
  • Analyst Decision
  • IPWR Hold
  • PRLD Strong Buy
  • Analyst Count
  • IPWR 1
  • PRLD 2
  • Target Price
  • IPWR N/A
  • PRLD $4.50
  • AVG Volume (30 Days)
  • IPWR 63.9K
  • PRLD 224.4K
  • Earning Date
  • IPWR 08-13-2025
  • PRLD 08-11-2025
  • Dividend Yield
  • IPWR N/A
  • PRLD N/A
  • EPS Growth
  • IPWR N/A
  • PRLD N/A
  • EPS
  • IPWR N/A
  • PRLD N/A
  • Revenue
  • IPWR $19,296.00
  • PRLD $7,000,000.00
  • Revenue This Year
  • IPWR N/A
  • PRLD N/A
  • Revenue Next Year
  • IPWR $5,900.00
  • PRLD N/A
  • P/E Ratio
  • IPWR N/A
  • PRLD N/A
  • Revenue Growth
  • IPWR N/A
  • PRLD N/A
  • 52 Week Low
  • IPWR $3.77
  • PRLD $0.61
  • 52 Week High
  • IPWR $9.69
  • PRLD $6.80
  • Technical
  • Relative Strength Index (RSI)
  • IPWR 53.15
  • PRLD 42.16
  • Support Level
  • IPWR $3.81
  • PRLD $0.77
  • Resistance Level
  • IPWR $4.77
  • PRLD $0.84
  • Average True Range (ATR)
  • IPWR 0.38
  • PRLD 0.07
  • MACD
  • IPWR 0.05
  • PRLD -0.02
  • Stochastic Oscillator
  • IPWR 85.58
  • PRLD 16.04

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: